<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-13152</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0112414</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Multiple sclerosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Complementary and alternative medicine</subject></subj-group><subj-group><subject>Neurology</subject><subj-group><subject>Demyelinating disorders</subject></subj-group></subj-group><subj-group><subject>Sports and exercise medicine</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Yoga for Multiple Sclerosis: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Yoga for Multiple Sclerosis: A Systematic Review and Meta-Analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>Holger</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lauche</surname><given-names>Romy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Azizi</surname><given-names>Hoda</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dobos</surname><given-names>Gustav</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Langhorst</surname><given-names>Jost</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Manzoli</surname><given-names>Lamberto</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Chieti, Italy</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">h.cramer@kliniken-essen-mitte.de</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: HC RL JL. Performed the experiments: HC RL HA. Analyzed the data: HC. Contributed to the writing of the manuscript: HC RL GD JL.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>12</day><month>11</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>11</issue>
<elocation-id>e112414</elocation-id>
<history>
<date date-type="received"><day>24</day><month>3</month><year>2014</year></date>
<date date-type="accepted"><day>23</day><month>9</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Cramer et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>While yoga seems to be effective in a number of neuropsychiatric disorders, the evidence of efficacy in multiple sclerosis remains unclear. The aim of this review was to systematically assess and meta-analyze the available data on efficacy and safety of yoga in patients with multiple sclerosis. Medline/PubMed, Scopus, the Cochrane Central Register of Controlled Trials, PsycINFO, CAM-Quest, CAMbase, and IndMED were searched through March 2014. Randomized controlled trials (RCTs) of yoga for patients with multiple sclerosis were included if they assessed health-related quality of life, fatigue, and/or mobility. Mood, cognitive function, and safety were defined as secondary outcome measures. Risk of bias was assessed using the Cochrane tool. Seven RCTs with a total of 670 patients were included. Evidence for short-term effects of yoga compared to usual care were found for fatigue (standardized mean difference [SMD] = −0.52; 95% confidence intervals (CI) = −1.02 to −0.02; p = 0.04; heterogeneity: I<sup>2</sup> = 60%; Chi<sup>2</sup> = 7.43; p = 0.06) and mood (SMD = −0.55; 95%CI = −0.96 to −0.13; p = 0.01; heterogeneity: I<sup>2</sup> = 0%; Chi<sup>2</sup> = 1.25; p = 0.53), but not for health-related quality of life, muscle function, or cognitive function. The effects on fatigue and mood were not robust against bias. No short-term or longer term effects of yoga compared to exercise were found. Yoga was not associated with serious adverse events. In conclusion, since no methodological sound evidence was found, no recommendation can be made regarding yoga as a routine intervention for patients with multiple sclerosis. Yoga might be considered a treatment option for patients who are not adherent to recommended exercise regimens.</p>
</abstract>
<funding-group><funding-statement>This review was supported by a grant from the Rut- and Klaus-Bahlsen-Foundation. The funding source had no influence on the design or conduct of the review; the collection, management, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript.</funding-statement></funding-group><counts><page-count count="11"/></counts><custom-meta-group><custom-meta id="data-availability" xlink:type="simple"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. Data are available from the published RCTs from which they were extracted.</meta-value></custom-meta></custom-meta-group></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Multiple sclerosis is the most common chronic autoimmune inflammatory disease of the central nervous system and the leading cause of disability in young adults <xref ref-type="bibr" rid="pone.0112414-Compston1">[1]</xref>, <xref ref-type="bibr" rid="pone.0112414-Noseworthy1">[2]</xref>. Multiple sclerosis is mainly characterized by impaired health-related quality of life, fatigue, and reduced mobility <xref ref-type="bibr" rid="pone.0112414-Compston1">[1]</xref>–<xref ref-type="bibr" rid="pone.0112414-Riazi1">[3]</xref>. Other common symptoms include cognitive impairment, depression, and emotional lability <xref ref-type="bibr" rid="pone.0112414-Compston1">[1]</xref>, <xref ref-type="bibr" rid="pone.0112414-Noseworthy1">[2]</xref>.</p>
<p>Yoga is rooted in Indian philosophy and has been a part of traditional Indian spiritual practice for millennia <xref ref-type="bibr" rid="pone.0112414-Feuerstein1">[4]</xref>. Yoga traditionally is a complex intervention that comprises not only physical activity but also advice for ethical lifestyle, spiritual practice, breathing exercises, and meditation. While the ultimate goal of traditional yoga has been described as uniting mind, body, and spirit, yoga has become a popular means to promote physical and mental well-being <xref ref-type="bibr" rid="pone.0112414-Feuerstein1">[4]</xref>, <xref ref-type="bibr" rid="pone.0112414-Iyengar1">[5]</xref>. In North America and Europe, yoga is most often associated with physical postures (asanas), breathing techniques (pranayama), and meditation (dhyana); and different yoga forms have emerged that put varying focus on physical and mental practices <xref ref-type="bibr" rid="pone.0112414-Feuerstein1">[4]</xref>. In North America and Europe, yoga is gaining increased popularity as a therapeutic method. About 14 million adult Americans (more than 6% of the population) reported that yoga had been recommended to them by a physician or therapist <xref ref-type="bibr" rid="pone.0112414-Macy1">[6]</xref>. Indeed, about half of American yoga practitioners (more than 13 million people) reported that they had started practice explicitly to improve their health <xref ref-type="bibr" rid="pone.0112414-Barnes1">[7]</xref>, <xref ref-type="bibr" rid="pone.0112414-Barnes2">[8]</xref>.</p>
<p>While systematic reviews and meta-analyses have evaluated the efficacy and safety of yoga for a number neuropsychiatric disorders <xref ref-type="bibr" rid="pone.0112414-Vancampfort1">[9]</xref>–<xref ref-type="bibr" rid="pone.0112414-Cramer2">[11]</xref>, the evidence of efficacy of yoga in multiple sclerosis has not yet been systematically assessed. Thus, the aim of this review was to systematically evaluate and meta-analyze the available data on efficacy and safety of yoga in improving health-related quality of life, fatigue, mobility, mood, and cognitive function in patients with multiple sclerosis.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<p>This review was planned and conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines <xref ref-type="bibr" rid="pone.0112414-Moher1">[12]</xref> (<xref ref-type="supplementary-material" rid="pone.0112414.s002">Checklist S1</xref>) and recommendations of the Cochrane Collaboration <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>. The review protocol was developed a priori and not modified during the conduct of the review.</p>
<sec id="s2a">
<title>Eligibility criteria</title>
<sec id="s2a1">
<title>Types of studies</title>
<p>Randomized controlled trials (RCTs), randomized cross-over studies, and cluster-randomized trials were eligible. No language restrictions were applied.</p>
</sec><sec id="s2a2">
<title>Types of participants</title>
<p>Studies on adult patients (≥18 years) with a diagnosis of multiple sclerosis were eligible.</p>
</sec><sec id="s2a3">
<title>Types of interventions</title>
<p><italic>Experimental:</italic> Studies on yoga interventions including at least one of the following: physical activity, breath control, meditation, and/or lifestyle advice (based on yoga theory and/or traditional yoga practices) were eligible. No restrictions were made regarding yoga tradition, length, frequency or duration of the program. Studies on multimodal interventions that include yoga amongst others were excluded. Studies allowing individual co-interventions were eligible.</p>
<p><italic>Control:</italic> Studies comparing yoga to usual care, exercise, or other active non-pharmacological control interventions were eligible.</p>
</sec><sec id="s2a4">
<title>Types of outcome measures</title>
<p>To be eligible for inclusion, studies had to assess at least one primary outcome as recommended by an international, multi-disciplinary consensus meeting <xref ref-type="bibr" rid="pone.0112414-Paul1">[14]</xref>:</p>
<list list-type="order"><list-item>
<p>Health-related quality of life, assessed using validated disease-specific instruments such as the Multiple Sclerosis Impact Scale or the Multiple Sclerosis Quality of Life Scale; or generic instruments. Where available, disease-specific instruments were preferred.</p>
</list-item><list-item>
<p>Fatigue, assessed using validated instruments such as the Fatigue Severity Scale or the Modified Fatigue Impact Scale.</p>
</list-item><list-item>
<p>Mobility/muscle function, assessed using objective physician-rated tests such as the 6 minute walk test.</p>
</list-item></list>
<p>Secondary outcomes included:</p>
<list list-type="order"><list-item>
<p>Mood, assessed using validated instruments for depression or anxiety.</p>
</list-item><list-item>
<p>Cognitive function, assessed using validated neuropsychological tests.</p>
</list-item><list-item>
<p>Safety of the intervention, assessed as number of patients with adverse events (AEs).</p>
</list-item></list>
</sec></sec><sec id="s2b">
<title>Search methods</title>
<p>The search strategy comprised seven electronic databases from their inception through March 01, 2014: Medline/PubMed, Scopus, the Cochrane Central Register of Controlled Trials, PsycINFO, CAM-Quest, CAMbase, and IndMED. The literature search was constructed around search terms for 1. “yoga” and 2. “multiple sclerosis” and adapted for each database as necessary. The complete search strategy for Medline was as follows: (“Multiple Sclerosis”[Mesh] OR “Multiple Sclerosis”[Title/Abstract] OR “MS”[Title/Abstract] OR “Disseminated Sclerosis”[Title/Abstract]) AND (“Yoga”[Mesh] OR “Yoga”[Title/Abstract] OR “Yogic”[Title/Abstract] OR “Asana”[Title/Abstract] OR “Pranayama”[Title/Abstract] OR “Dhyana”[Title/Abstract]). Additionally, reference lists of identified original articles or reviews; and the tables of contents of the International Journal of Yoga Therapy and the Journal of Yoga &amp; Physical Therapy were searched manually.</p>
<p>Two reviewers independently screening and selected abstracts; potentially eligible articles were read in full by two reviewers. Disagreements were settled through a discussion with a third reviewer until consensus was reached. If necessary, additional information was obtained from the authors of the primary study.</p>
</sec><sec id="s2c">
<title>Data extraction and management</title>
<p>Two reviewers independently extracted data on patients (e.g. age, gender, ethnicity), methods (e.g. randomization, allocation concealment), interventions (e.g. yoga type, frequency, and duration), control interventions (e.g. type, frequency, duration), outcomes (e.g. outcome measures, assessment time points), and results using an a priori developed data extraction form. Discrepancies were discussed with a third reviewer until consensus was reached.</p>
</sec><sec id="s2d">
<title>Assessment of risk of bias in individual studies</title>
<p>Two reviewers independently assessed risk of bias using the Cochrane risk of bias tool <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>. This tool assesses risk of bias on seven domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. For each domain, risk of bias was assessed as low; unclear; or high risk of bias. Discrepancies were discussed with a third reviewer until consensus was achieved.</p>
</sec><sec id="s2e">
<title>Data analysis</title>
<sec id="s2e1">
<title>Assessment of overall effect size</title>
<p>Separate meta-analyses were conducted for comparisons of yoga to different control interventions. Meta-analyses were conducted using Review Manager 5 software (Version 5.1, The Nordic Cochrane Centre, Copenhagen) by random effects models if at least two studies assessing this specific outcome were available. For continuous outcomes, standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated as the difference in means between groups divided by the pooled standard deviation using Hedges’s correction for small study samples <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>. Where no standard deviations were available, they were calculated from standard errors, confidence intervals or t-values <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>, or attempts were made to obtain the missing data from the trial authors by email.</p>
<p>A positive SMD (i.e. higher values in the yoga group) was defined to indicate beneficial effects of yoga compared to the control intervention for quality of life, mobility, and cognitive function while a negative SMD (i.e. lower values in the yoga group) was defined to indicate beneficial effects for fatigue and mood. If necessary, values were inverted <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>.</p>
<p>Cohen’s categories were used to evaluate the magnitude of the overall effect size with SMD = 0.2–0.5: small; SMD = 0.5–0.8: medium; and SMD&gt;0.8: large effect sizes <xref ref-type="bibr" rid="pone.0112414-Cohen1">[15]</xref>.</p>
</sec></sec><sec id="s2f">
<title>Assessment of heterogeneity</title>
<p>Statistical heterogeneity between studies was analyzed using the I<sup>2</sup> statistics, a measure of how much variance between studies can be attributed to differences between studies rather than chance. The magnitude of heterogeneity was categorized as (1) I<sup>2</sup> = 0–24%: low heterogeneity; I<sup>2</sup> = 25–49%: moderate; I<sup>2</sup> = 50–74%: substantial; and I<sup>2</sup> = 75–100%: considerable <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>, <xref ref-type="bibr" rid="pone.0112414-Higgins2">[16]</xref>. The Chi<sup>2</sup> test was used to assess whether differences in results are compatible with chance alone. Given the low power of this test when only few studies or studies with low sample size are included in a meta-analysis, a P-value≤0.10 was regarded to indicate significant heterogeneity <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>.</p>
</sec><sec id="s2g">
<title>Subgroup and sensitivity analyses</title>
<p>Subgroup analyses were planned for the type of yoga intervention (yoga interventions including physical postures vs. yoga interventions without physical postures). As all included studies comprised yoga postures, subgroup analyses could not be performed.</p>
<p>To test the robustness of significant results, sensitivity analyses were conducted for studies with high versus low risk of bias at the following domains: selection bias (random sequence generation and allocation concealment), detection bias (blinding of outcome assessment), and attrition bias (incomplete outcome data).</p>
<p>If present in the respective meta-analysis, subgroup and sensitivity analyses were also used to explore possible reasons for statistical heterogeneity.</p>
</sec><sec id="s2h">
<title>Risk of bias across studies</title>
<p>If at least 10 studies were included in a meta-analysis, assessment of publication bias was originally planned by using funnel plots generated using Review Manager software <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>, <xref ref-type="bibr" rid="pone.0112414-Egger1">[17]</xref>. As less than 10 studies were included in each meta-analysis, funnel plots could not be analyzed.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Literature search</title>
<p>The literature search retrieved 96 non-duplicate records of which 87 were excluded on the basis of title and abstract because they did not meet all pre-defined inclusion criteria (<xref ref-type="supplementary-material" rid="pone.0112414.s001">Table S1</xref>). Nine full-text articles were assessed for eligibility <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>. All nine full-text articles reporting on seven RCTs involving a total of 670 patients met the inclusion criteria and were included in the qualitative analysis and meta-analysis (<xref ref-type="fig" rid="pone-0112414-g001">Figure 1</xref>). One full-text article was published in Persian <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>, the others in English.</p>
<fig id="pone-0112414-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.g001</object-id><label>Figure 1</label><caption>
<title>Flowchart of the results of the literature search.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>Study characteristics</title>
<p>Characteristics of the sample, interventions, outcome assessment, and results are shown in <xref ref-type="table" rid="pone-0112414-t001">Table 1</xref>.</p>
<table-wrap id="pone-0112414-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of the included studies.</title>
</caption><alternatives><graphic id="pone-0112414-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Reference</td>
<td align="left" rowspan="1" colspan="1">Origin</td>
<td align="left" rowspan="1" colspan="1">Sample</td>
<td align="left" rowspan="1" colspan="1">Intervention</td>
<td align="left" rowspan="1" colspan="1">Control group</td>
<td align="left" rowspan="1" colspan="1">Outcomeassessmenttime point</td>
<td align="left" rowspan="1" colspan="1">Outcomemeasures:</td>
<td align="left" rowspan="1" colspan="1">Resultspost-intervention (between groupdifferences, if nototherwise stated)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Country; Recruitedfrom</td>
<td align="left" rowspan="1" colspan="1">Sample size; diagnosis; current treatment; mean age; ethnicity</td>
<td align="left" rowspan="1" colspan="1">Intervention; programlength; frequency; duration</td>
<td align="left" rowspan="1" colspan="1">Intervention; programlength; frequency; duration</td>
<td align="left" rowspan="1" colspan="1">Post-intervention; longestfollow-up</td>
<td align="left" rowspan="1" colspan="1">1. Quality of life; 2. Fatigue; 3. Muscle function/mobility (walking distance); 4. Mood; 5. Cognitive function; 6. Safety</td>
<td align="left" rowspan="1" colspan="1">1. Quality of life; 2. Fatigue; 3. Musclefunction/mobility (walking distance); 4. Mood; 5. Cognitive function; 6. Safety</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ahmadi,2010, 2013 <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref></td>
<td align="left" rowspan="1" colspan="1">Iran;physiotherapyclinic</td>
<td align="left" rowspan="1" colspan="1">31 women; MS diagnosed by physician; diseasemodifying drugs were allowed; 35.2±9.0 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Hatha Yoga; 8 weeks; 3x/weeks; 60–70 min each (postures, breathing techniques, meditation)</td>
<td align="left" rowspan="1" colspan="1">Control group 1) Exercise (treadmill training) 8 weeks; 3x/weeks; 30 min each; Control group 2) Usual care</td>
<td align="left" rowspan="1" colspan="1">8 weeks</td>
<td align="left" rowspan="1" colspan="1">1. MSQOL54: physical healthcomposite, mental health composite; 2. FSS; 3. 10-mtimed walk test, 2-min walk test; 4. BDI, BAI; 5. NA; 6. Exacerbation</td>
<td align="left" rowspan="1" colspan="1">1. Sign. improvements in Yoga, but not in Usual care; 2. Sign. improvements in Yoga and Exercise, but not in Usual care; 3. Sign. improvements in Yoga and Exercise, but not in Usual care; 4. BDI,BAI: sign. Improvements in Yogaand Exercise, but not in Usual care; 5. NA; 6. No exacerbations</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Doulatabad 2013 <xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref></td>
<td align="left" rowspan="1" colspan="1">Iran; university hospital</td>
<td align="left" rowspan="1" colspan="1">60 women; MS not in acute phase; current treatment NR; 31.6±8.0 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Hatha Yoga; 12 weeks; 2x/week; 60–90 min. each (postures, breathing techniques, meditation)</td>
<td align="left" rowspan="1" colspan="1">Usual care</td>
<td align="left" rowspan="1" colspan="1">12 weeks</td>
<td align="left" rowspan="1" colspan="1">1. MSQOL54;2.-6. NA</td>
<td align="left" rowspan="1" colspan="1">1. Sign. improvements in Yoga, but not in Usual care; 2.-6. NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Garret 2013<xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">Ireland; Multiple Sclerosis Society of Ireland</td>
<td align="left" rowspan="1" colspan="1">314; MS diagnosed by physician or neurologist;no steroid treatment; 48.8±11.0 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Yoga, not predefined; 10 weeks; 1x/week; 1 hour each (postures, breathing techniques, relaxation)</td>
<td align="left" rowspan="1" colspan="1">Control group 1)Physiotherapist led exercise(aerobic, resistance); 10 weeks; 1x/week; 1 hour each;Control group 2) Fitness instructor led exercise(aerobic, resistance); 10 weeks; 1x/week; 1 hour each; Control group 3) Usual care</td>
<td align="left" rowspan="1" colspan="1">12 weeks;24 weeks</td>
<td align="left" rowspan="1" colspan="1">1. MSIS-29v2: physical health composite, mental health composite; 2. MFIS; 3. 6-minwalk test; 4.-5. NA; 6. Drop outs due to medicalreasons</td>
<td align="left" rowspan="1" colspan="1">1. Sign. improvements in Yoga and Exercise groups, but not in Usual care; sign. larger improvement in Yogacompared to Usual care for mental health composite only; 2. Sign. improvements in Yoga and Exercise groups, but not in Usual care; sign. larger improvement in Yogacompared to Usual care; 3. NS; 4.-5. NA; 6. N = 3/77 in Yoga, N = 4/80 in Physiotherapist led exercise; N = 5/86 in Fitness instructor led exercise, N = 8/71 in Usual care</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hogan 2014 <xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref></td>
<td align="left" rowspan="1" colspan="1">Ireland; Multiple Sclerosis Society of Ireland</td>
<td align="left" rowspan="1" colspan="1">146; MS diagnosed by physician orneurologist; no steroidtreatment; 54.4 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Yoga, not predefined; 10 weeks; 1x/week; 1 hour each (postures, breathing techniques, relaxation)</td>
<td align="left" rowspan="1" colspan="1">Control group 1) Individual physiotherapy (aerobic, resistance exercise); 10 weeks;1x/week; 1 hour each; Control group 2) Group led physiotherapy (aerobic, resistance exercise); 10 weeks; 1x/week; 1 hour each;Control group 3) Usual care</td>
<td align="left" rowspan="1" colspan="1">12 weeks</td>
<td align="left" rowspan="1" colspan="1">1. MSIS-29v2: physical health composite, mental healthcomposite; 2. MFIS; 3. 6-minwalk test; 4.-5. NA; 6. Drop outs due to medical reasons</td>
<td align="left" rowspan="1" colspan="1">1. Sign. improvements in Group Physiotherapy, but not Yoga or Usual Care; Sign. improvements in individual physiotherapy for physical health composite only; 2. Sign. improvements in exercise groups, but not Yoga or Usual Care; 3. Sign. improvements in group physiotherapy, but not Yoga or Usual Care; 4.-5. NA; 6. N = 0/16 in Yoga, N = 2/66 in Group Physiotherapy; N = 2/45 in Individual Physiotherapy, N = 1/19 in Usual care</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Oken 2004<xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref></td>
<td align="left" rowspan="1" colspan="1">North America; adverts and newsletters of MS societies</td>
<td align="left" rowspan="1" colspan="1">69 patients with MS; medical records; no change in CNS-active medications; 49.0 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Iyengar yoga; 6 months; 1x/week; 90 min each; daily home practice(postures, breathing techniques, relaxation)</td>
<td align="left" rowspan="1" colspan="1">Control group 1) Aerobic exercise; 6 months;1x/week; 90 min each; daily home practice;Control group 2) Usual care</td>
<td align="left" rowspan="1" colspan="1">6 months</td>
<td align="left" rowspan="1" colspan="1">1. SF-36: physical healthcomposite, mental healthcomposite; 2. MFI; 3. 25-foottimed walk test; 4. POMS; CES-D; STAI; 5. Attention (Stroop Color and Word Test, modified Useful Field of View task, adapted attentional shift task, PASAT, Wechsler Memory Scales III Logical Memory, Wechsler Adult IntelligenceScale III Similarities); alertness (EEG, SSS); 5. NA; 6. Adverse events</td>
<td align="left" rowspan="1" colspan="1">1.-4. NS; 5. NA; 6. 3 surgeries; 1 exacerbation in Yoga and Exercise each</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rahnama 2011<xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref></td>
<td align="left" rowspan="1" colspan="1">Iran; Multiple Sclerosis Foundation</td>
<td align="left" rowspan="1" colspan="1">30 women with MS; under medication therapy; 33.4 years, ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Yoga; 8 weeks; 2x/week; 60–75 min each; 1x/week home practice (postures, relaxation)</td>
<td align="left" rowspan="1" colspan="1">Usual care</td>
<td align="left" rowspan="1" colspan="1">8 weeks</td>
<td align="left" rowspan="1" colspan="1">1.-3. NA; 4. BDI; 5.-6. NA</td>
<td align="left" rowspan="1" colspan="1">1.-3. NA; 4. Sign. improvement in Yoga, but not in Usual care; 5.-6. NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Velikonja 2010<xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref></td>
<td align="left" rowspan="1" colspan="1">Slovenia; recruitment NR</td>
<td align="left" rowspan="1" colspan="1">20 patients with MS; primary or secondary progressive MS; current treatment NR; age between 26 and 50 years; ethnicity NR</td>
<td align="left" rowspan="1" colspan="1">Hatha Yoga; 10 weeks; 1x/week (postures, breathing techniques)</td>
<td align="left" rowspan="1" colspan="1">Exercise (Sports climbing)</td>
<td align="left" rowspan="1" colspan="1">10 weeks</td>
<td align="left" rowspan="1" colspan="1">1. NA; 2. MFIS; 3. NA; 4. CES-D 5. Executivefunctions (NAB, TOL), attention (d2CP); 6. NA</td>
<td align="left" rowspan="1" colspan="1">1. NA; 2. Sign. improvement in Exercise, but not in Yoga; 3. NA; 4. NS; 5. Sign. improvement in Yoga, but not in Exercise; 6. NA</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Abbreviations: BAI – Beck Anxiety Inventory; BDI – Beck Depression Inventory; CES-D - Center for Epidemiological Studies Depression Scale; d2CP – Brickenkamp d2 test concentration performance; FSS – Fatigue Severity Scale; MAS – Modified Ashworth Scale; MFI – Multidimensional Fatigue Inventory; MFIS – Modified Fatigue Impact Scale; MS – multiple sclerosis; MSIS-29v2– Multiple Sclerosis Impact Scale-29, version2; MSQOL54 - Multiple Sclerosis Quality of Life 54; NA – Not assessed; NAB – Neuropsychological Assessment Battery; NR – not reported; NS – not significant; PASAT – Paced Auditory Serial Addition Test; POMS – Profile of Mood States; SF-36 - Short Form-36 Health Survey; SSS – Stanford Sleepiness Scale; STAI – State Trait Anxiety Inventory; TOL – Tower of London Test.</p></fn></table-wrap-foot></table-wrap><sec id="s3b1">
<title>Study and participant characteristics</title>
<p>Of the seven studies that were included, three originated from Iran <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref>, <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>; two from Ireland <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>; and one each from the USA <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>; and Slovenia <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>. Patients were recruited from hospitals <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref>, multiple sclerosis societies <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref> or multiple sclerosis foundations <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>. Only three studies reported on the type of multiple sclerosis, all three studies included patients with all types of multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>. The sample size ranged from 20 to 314 with a median of 60. Participant’s mean age ranged from 31.6 to 54.4 years with a median of 42 years. Between 75.2% and 100.0% of participants were female (median 96.5%). Ethnicity was not reported in any study.</p>
</sec><sec id="s3b2">
<title>Intervention characteristics</title>
<p>Three studies used Hatha Yoga <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>; one used Iyengar Yoga <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>; two did not predefine the yoga intervention but let the yoga teachers decide on content of the intervention <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>; and one did not report the yoga style used <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>. All seven studies used yoga postures and meditation or relaxation; six also used yogic breathing techniques <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>. The duration of yoga programs ranged from eight weeks to six months with a median of 10 weeks; frequency of yoga interventions ranged from one to three (median: 1) weekly yoga sessions of 60 to 90 (median: 66.25) minutes length. Six studies compared yoga to usual care or no specific treatment <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>. Five studies compared yoga to exercise including treadmill training <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>; aerobic exercise <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>; mixed aerobic and resistance exercise <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>; or sports climbing <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>. Except for one study where the yoga sessions were longer in duration than the exercise session <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, the yoga and exercise interventions were exactly matched for program length, and frequency and duration of the sessions.</p>
</sec><sec id="s3b3">
<title>Outcome measures</title>
<p>All seven studies assessed outcomes immediately after the end of the intervention; one study also assessed longer-term effects 12 weeks after the end of the intervention <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>. Health-related quality of life was assessed in five studies using the Multiple Sclerosis Quality of Life 54 <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref>, the Multiple Sclerosis Impact Scale-29 <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>, or the Short Form-36 Health Survey <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>. Five studies assessed fatigue with the Fatigue Severity Scale <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, the Modified Fatigue Impact Scale <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>, or the Multidimensional Fatigue Inventory <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>. Mobility was assessed using the 10-m timed walk test <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, the 25-foot timed walk test <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, the 2-minute walk test <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, or the 6-minute walk test <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>. Mood was assessed in three studies using the Beck Depression Inventory <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>, the Beck Anxiety Inventory <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, the Profile of Mood States <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, the Center for Epidemiological Studies Depression Scale <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>, and/or the State Trait Anxiety Inventory <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>. Two studies assessed cognitive function using standardized neuropsychological test batteries <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref> (<xref ref-type="table" rid="pone-0112414-t002">table 2</xref>). Four studies reported safety-related data <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>, <xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>, <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>.</p>
<table-wrap id="pone-0112414-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.t002</object-id><label>Table 2</label><caption>
<title>Sensitivity analysis: effect sizes when only trials with low risk of detection bias were included.</title>
</caption><alternatives><graphic id="pone-0112414-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Comparison/Outcome</td>
<td align="left" rowspan="1" colspan="1">No. of studies</td>
<td align="left" rowspan="1" colspan="1">No. ofpatients (yoga)</td>
<td align="left" rowspan="1" colspan="1">No. ofpatients(control)</td>
<td align="left" rowspan="1" colspan="1">Standardizedmean difference(95% confidence interval)</td>
<td align="left" rowspan="1" colspan="1">P(overall effect)</td>
<td align="left" rowspan="1" colspan="1">HeterogeneityI<sup>2</sup>; Chi<sup>2</sup>; P</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Yoga versus usual care</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Quality of life</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">−0.00 (−0.30; 0.29)</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
<td align="left" rowspan="1" colspan="1">0%; 0.17; 0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fatigue</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">−0.32 (−0.72; 0.08)</td>
<td align="left" rowspan="1" colspan="1">0.12</td>
<td align="left" rowspan="1" colspan="1">36%; 3.14; 0.21</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mobility</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">−0.20 (−0.80; 0.41)</td>
<td align="left" rowspan="1" colspan="1">0.52</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mood</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">−0.63 (−1.25; −0.01)</td>
<td align="left" rowspan="1" colspan="1">0.05</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Yoga versus exercise</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Quality of life</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">230</td>
<td align="left" rowspan="1" colspan="1">0.09 (−0.15; 0.34)</td>
<td align="left" rowspan="1" colspan="1">0.46</td>
<td align="left" rowspan="1" colspan="1">0%; 0.16; 0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fatigue</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">230</td>
<td align="left" rowspan="1" colspan="1">0.05(−0.21; 0.31)</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
<td align="left" rowspan="1" colspan="1">5%; 2.11; 0.35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mobility</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">−0.20 (−0.85; 0.44)</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mood</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.31 (−0.34; 0.96)</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cognitive function</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.26 (−0.39; 0.91)</td>
<td align="left" rowspan="1" colspan="1">0.43</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec></sec><sec id="s3c">
<title>Risk of bias in individual studies</title>
<p>Risk of bias in individual studies is shown in <xref ref-type="fig" rid="pone-0112414-g002">figure 2</xref>. One study each had reported adequate random sequence generation <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref> or allocation concealment <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>; and three studies each reported adequate blinding of outcome assessement <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref> or were free of suspected selective reported <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>.</p>
<fig id="pone-0112414-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.g002</object-id><label>Figure 2</label><caption>
<title>Risk of bias for each criterion for each included study (top) and risk of bias for each criterion presented as percentages across all included studies (bottom).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.g002" position="float" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>Analysis of overall effect</title>
<sec id="s3d1">
<title>Primary outcomes</title>
<p>Meta-analyses revealed evidence for short-term effects of yoga compared to usual care on fatigue (SMD = −0.52; 95% CI = −1.02 to −0.02; p = 0.04) but not on health-related quality of life (SMD = 0.06; 95% CI = −0.19 to 0.30; p = 0.64) or mobility (SMD = −0.20; 95% CI = −0.69 to 0.30; p = 0.42). No evidence for effects of yoga compared to exercise was found for fatigue (SMD = 0.03; 95% CI = −0.24 to 0.30; p = 0.83), health-related quality of life (SMD = 0.09; 95% CI = −0.15 to 0.34; p = 0.46), or mobility (SMD = −0.11; 95% CI = −0.63 to 0.41; p = 0.68) was found (<xref ref-type="fig" rid="pone-0112414-g003">figure 3</xref>). while no meta-analysis was possible, based on single RCTs no evidence for longer-term effects of yoga compared to exercise on health-related quality of life, fatigue, or mobility was found <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>.</p>
<fig id="pone-0112414-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.g003</object-id><label>Figure 3</label><caption>
<title>Effect sizes for the primary outcomes quality of life, fatigue, and mobility.</title>
<p>*both exercise groups combined; **means and standard deviations provided upon request.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3d2">
<title>Secondary outcomes</title>
<p>Evidence for short-term effects of yoga compared to usual care was found for mood (SMD = −0.55; 95% CI−0.96, −0.12; p = 0.01) (<xref ref-type="fig" rid="pone-0112414-g004">figure 4</xref>). No evidence for short-term effects of yoga compared to exercise on mood (SMD = 0.16; 95% CI−0.40 to 0.72; p = 0.58) or cognitive function (SMD = 0.41; 95% CI−0.11 to 0.94; p = 0.12) was found (<xref ref-type="fig" rid="pone-0112414-g004">figure 4</xref>, <xref ref-type="table" rid="pone-0112414-t002">table 2</xref>).</p>
<fig id="pone-0112414-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0112414.g004</object-id><label>Figure 4</label><caption>
<title>Effect sizes for the secondary outcomes mood and cognitive function.</title>
<p>*standard deviation imputed from other studies; **means and standard deviations provided upon request.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0112414.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s3d3">
<title>Safety</title>
<p>Four studies reported safety-related data. One of those reported adverse events: one exacerbation in each group occurred, and four further adverse events were reported that were not related to the study interventions <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>. In another study, no exacerbation occurred in any of the three groups <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>, <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>. In another study, three patients in the yoga group were lost to follow-up after the intervention due to medical reasons (including exacerbations) compared to four, five, and eight patients in the physiotherapist-led exercise, fitness instructor-led exercise, and usual care group, respectively <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>. In the fourth study, zero, two, three, and one patients were lost to follow-up after the intervention due to medical reasons in the yoga, group physiotherapy, individual physiotherapy, and control group, respectively <xref ref-type="bibr" rid="pone.0112414-Hogan1">[23]</xref>.</p>
</sec></sec><sec id="s3e">
<title>Sensitivity analyses</title>
<p>Since no study had low risk of selection or attrition bias, no effect remained significant in sensitivity analyses for low risk of selection or attrition bias. In studies with low risk of detection bias, the effect of yoga compared to usual care on mood did not change substantially (SMD = −0.63; 95% CI−1.25, −0.01; p = 0.05). No other effects remained significant (<xref ref-type="table" rid="pone-0112414-t002">table 2</xref>).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<sec id="s4a">
<title>Summary of evidence</title>
<p>In this systematic review of seven randomized trials on yoga for multiple sclerosis, evidence for positive short-term effects of yoga on fatigue and mood, but not on more objective physician-rated outcomes such as mobility or cognitive function were found. No effect was robust against potential methodological bias. Although the overall high risk of bias hinders definite conclusions, yoga seems to be equally effective as exercise interventions in improving both patient-reported and physician-rated outcomes.</p>
<p>Safety of the intervention was insufficiently reported. Specifically, only one study explicitly assessed adverse events. However, exacerbations of multiple sclerosis were fewer or equal in number in the groups compared to the usual care or exercise groups. This is in line with previous cross-sectional studies <xref ref-type="bibr" rid="pone.0112414-Cramer3">[27]</xref>, <xref ref-type="bibr" rid="pone.0112414-Cramer4">[28]</xref> and systematic reviews of yoga interventions in other patient populations that found no evidence for serious yoga-associated adverse events <xref ref-type="bibr" rid="pone.0112414-Cramer5">[29]</xref>–<xref ref-type="bibr" rid="pone.0112414-Cramer9">[33]</xref>. It should however be considered that yoga has occasionally been associated with serious adverse events in case studies <xref ref-type="bibr" rid="pone.0112414-Cramer10">[34]</xref>.</p>
</sec><sec id="s4b">
<title>Agreements with prior systematic reviews</title>
<p>No systematic review specifically on yoga for multiple sclerosis was available. However, a recent review on studies on mind-body medicine for multiple sclerosis published until March 2012 <xref ref-type="bibr" rid="pone.0112414-Senders1">[35]</xref> included one RCT on yoga <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>. This review concluded that while yoga improved multiple sclerosis-related fatigue with fewer side effects than conventional treatment, more research was needed to draw definite conclusions. A recent systematic review on exercise for multiple sclerosis concluded that exercise therapy including yoga <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref> may have beneficial effects on patients with multiple sclerosis without adverse events and might thus be recommended for the rehabilitation of multiple sclerosis patients <xref ref-type="bibr" rid="pone.0112414-S1">[36]</xref>. A systematic review on yoga for fatigue that also conducted a meta-analysis included two trials on multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref> amongst trials other conditions. This meta-analysis found moderate evidence for effects of yoga on fatigue with larger effect sizes in non-cancer populations <xref ref-type="bibr" rid="pone.0112414-Boehm1">[37]</xref>. The recent guideline on complementary and alternative medicine in multiple sclerosis by the American Academy of Neurology included a systematic review on studies of yoga for multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Yadav1">[38]</xref>, <xref ref-type="bibr" rid="pone.0112414-Yadav2">[39]</xref>. This review included four studies <xref ref-type="bibr" rid="pone.0112414-Ahmadi2">[19]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref> and concluded that, mainly due the low power of the available trials, the data were inadequate to assess the effect of yoga on disability, spasticity, fatigue, cognition, mood, balance, or walking speed in patients with multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Yadav1">[38]</xref>, <xref ref-type="bibr" rid="pone.0112414-Yadav2">[39]</xref>.</p>
</sec><sec id="s4c">
<title>External and internal validity</title>
<p>Mainly patients from the Middle East and Europe were included. Given that ethnical and geographical factors influence the incidence and severity of multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Compston1">[1]</xref>, <xref ref-type="bibr" rid="pone.0112414-Noseworthy1">[2]</xref>, the applicability of these findings in other geographical regions is limited. Moreover, since mainly female patients were included, the results might not be fully applicable to male patients. Four studies did not report on the eligible types of multiple sclerosis <xref ref-type="bibr" rid="pone.0112414-Ahmadi1">[18]</xref>–<xref ref-type="bibr" rid="pone.0112414-Doulatabad1">[20]</xref>, <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref>, <xref ref-type="bibr" rid="pone.0112414-Rahnama1">[25]</xref>. This further limits the applicability of the results.</p>
<p>Overall, risk of bias of the included studies was unclear or high. Most importantly, only one study each reported adequate random sequence generation <xref ref-type="bibr" rid="pone.0112414-Oken1">[24]</xref> or allocation concealment <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>. As inadequate allocation concealment has been empirically demonstrated to be the most important source of bias in RCTs <xref ref-type="bibr" rid="pone.0112414-Schulz1">[40]</xref>, this strongly limits the interpretability of results. In sensitivity analyses, no effect was robust against all potential sources of bias. The internal validity of the results is thus limited.</p>
</sec><sec id="s4d">
<title>Strengths and weaknesses</title>
<p>To the best of our knowledge, this is the first systematic review and/or meta-analysis available on yoga for patients with multiple sclerosis. Strengths of this review include the comprehensive literature search without language restrictions and the assessment of applicability of the results <xref ref-type="bibr" rid="pone.0112414-Gartlehner1">[41]</xref>. The primary limitation of this review is the paucity of eligible studies, rendering subgroup analyses impossible and resulting in a relatively limited overall sample size. Another major limitation is the insufficient reporting and/or low methodological quality of the included studies, limiting the interpretability of the results. Moreover, the reliability of the Cochrane risk of bias tool in systematic reviews on clinical trials of behavioral interventions has been questioned. It has been demonstrated that there is poor inter-rater reliability for several of the domains, specifically for the domain ‘blinding of participants and personnel’ <xref ref-type="bibr" rid="pone.0112414-ArmijoOlivo1">[42]</xref>. Since it is generally regarded impossible to blind patients and therapists in trials of behavioral interventions such as yoga, different research groups tend to rate this domains differently if no information on blinding is provided. Accordingly, this domain was not used in sensitivity analyses. The applicability of the findings was limited. As only one study reported longer-term effects <xref ref-type="bibr" rid="pone.0112414-Garrett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0112414-Garrett2">[22]</xref>, the results of this review are only applicable to the short-term. No unpublished studies or studies published in ‘grey literature’ were included. The usefulness of including unpublished trials is still under debate <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>. Meant to address publication bias, only few unpublished trials can normally be located for systematic reviews and the located studies may be an unrepresentative sample of all unpublished studies <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>, <xref ref-type="bibr" rid="pone.0112414-Hetherington1">[43]</xref>. Investigators are often unwilling to provide unfavorable results; thus publication bias may still remain an issue <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>. Moreover, unpublished studies tend to be of lower methodological quality than published studies <xref ref-type="bibr" rid="pone.0112414-Egger2">[44]</xref> and normally lack peer-review <xref ref-type="bibr" rid="pone.0112414-Higgins1">[13]</xref>.</p>
</sec><sec id="s4e">
<title>Implications for further research</title>
<p>Given that the main drawback of this review was the insufficient reporting of trial methodology, authors of prospect research should improve the reporting of yoga trials and follow commonly accepted reporting guidelines (e.g. CONSORT) <xref ref-type="bibr" rid="pone.0112414-Schulz2">[45]</xref>. Future studies should ensure rigorous methodology, mainly adequate randomization, allocation concealment, intention-to-treat analysis, and blinding of at least outcome assessors <xref ref-type="bibr" rid="pone.0112414-Schulz2">[45]</xref>.</p>
</sec><sec id="s4f">
<title>Implications for clinical practice</title>
<p>While this review found evidence for effects of yoga on fatigue and mood in patients with multiple sclerosis, due to the insufficient reporting of the included trials and the limited external validity, this evidence should be applied in clinical practice with care. Thus, no recommendation can be made regarding yoga as a routine intervention for patients with multiple sclerosis at this point. Given that yoga was not associated with severe adverse events, its practice needs not be discouraged in this patient population. Given its evident effectiveness <xref ref-type="bibr" rid="pone.0112414-S1">[36]</xref>, exercise is strongly encouraged by international guideline for the treatment of multiple sclerosis-associated symptoms, especially for improving fatigue <xref ref-type="bibr" rid="pone.0112414-National1">[46]</xref>, <xref ref-type="bibr" rid="pone.0112414-LatimerCheung1">[47]</xref>, <xref ref-type="bibr" rid="pone.0112414-National2">[48]</xref>. Since fatigue seems to be equally improved by yoga and exercise, yoga might be considered a treatment option for patients who are not adherent to recommended exercise regimens.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0112414.s001" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pone.0112414.s001" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Records excluded after screening of title and abstract with reasons for exclusion.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pone.0112414.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0112414.s002" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA Checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>The authors would like to express their appreciation to Dr. Ana Ožura, Ljubljana, Slovenia for providing additional data for Ref <xref ref-type="bibr" rid="pone.0112414-Velikonja1">[26]</xref>.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0112414-Compston1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Compston</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Coles</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Multiple sclerosis</article-title>. <source>Lancet</source> <volume>372</volume>: <fpage>1502</fpage>–<lpage>1517</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Noseworthy1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Noseworthy</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lucchinetti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Weinshenker</surname><given-names>BG</given-names></name> (<year>2000</year>) <article-title>Multiple sclerosis</article-title>. <source>N Engl J Med</source> <volume>343</volume>: <fpage>938</fpage>–<lpage>952</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Riazi1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riazi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hobart</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Lamping</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Fitzpatrick</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <volume>74</volume>: <fpage>710</fpage>–<lpage>714</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Feuerstein1"><label>4</label>
<mixed-citation publication-type="other" xlink:type="simple">Feuerstein G (1998) The yoga tradition. Prescott: Hohm Press.</mixed-citation>
</ref>
<ref id="pone.0112414-Iyengar1"><label>5</label>
<mixed-citation publication-type="other" xlink:type="simple">Iyengar BKS (1966) Light on yoga. New York: Schocken Books.</mixed-citation>
</ref>
<ref id="pone.0112414-Macy1"><label>6</label>
<mixed-citation publication-type="other" xlink:type="simple">Macy D (2008) Yoga journal releases 2008 “Yoga in America” market study. Yoga Journal. Available: <ext-link ext-link-type="uri" xlink:href="http://www.yogajournal.com/advertise/press_releases/10" xlink:type="simple">http://www.yogajournal.com/advertise/press_releases/10</ext-link>. Accessed 7 March 2014.</mixed-citation>
</ref>
<ref id="pone.0112414-Barnes1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnes</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Bloom</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nahin</surname><given-names>RL</given-names></name> (<year>2008</year>) <article-title>Complementary and alternative medicine use among adults and children: United States, 2007</article-title>. <source>Natl Health Stat Report</source> <volume>(12)</volume>: <fpage>1</fpage>–<lpage>23</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Barnes2"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnes</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Powell-Griner</surname><given-names>E</given-names></name>, <name name-style="western"><surname>McFann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nahin</surname><given-names>RL</given-names></name> (<year>2004</year>) <article-title>Complementary and alternative medicine use among adults: United States, 2002</article-title>. <source>Advance data</source> <volume>(343)</volume>: <fpage>1</fpage>–<lpage>19</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Vancampfort1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vancampfort</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vansteelandt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Scheewe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Probst</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Knapen</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Yoga in schizophrenia: a systematic review of randomised controlled trials</article-title>. <source>Acta Psychiatr Scand</source> <volume>126</volume>: <fpage>12</fpage>–<lpage>20</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Klose</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Langhorst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>Yoga for schizophrenia: a systematic review and meta-analysis</article-title>. <source>BMC Psychiatry</source> <volume>13</volume>: <fpage>32</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer2"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langhorst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>Yoga for depression: a systematic review and meta-analysis</article-title>. <source>Depress Anxiety</source> <volume>20</volume>: <fpage>1068</fpage>–<lpage>83</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Moher1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2009</year>) <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>BMJ</source> <volume>339</volume>: <fpage>b2535</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Higgins1"><label>13</label>
<mixed-citation publication-type="other" xlink:type="simple">Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. West Sussex: John Wiley &amp; Sons Ltd.</mixed-citation>
</ref>
<ref id="pone.0112414-Paul1"><label>14</label>
<mixed-citation publication-type="other" xlink:type="simple">Paul L, Crosbie J, Coote S, Dixon D, Hale L, <etal>et al</etal>.. (2013) Outcome measures for studies of exercise in multiple sclerosis: recommendations from an international, multi-disciplinary consensus meeting. 29th Congress on the European Committee for Treatment and Research in Multiple Sclerosis. Available: <ext-link ext-link-type="uri" xlink:href="http://registrationakmch/einsichtphp?XNABSTRACT_ID=179215&amp;XNSPRACHE_ID=2&amp;XNKONGRESS_ID=195&amp;XNMASKEN_ID=900" xlink:type="simple">http://registrationakmch/einsichtphp?XNABSTRACT_ID=179215&amp;XNSPRACHE_ID=2&amp;XNKONGRESS_ID=195&amp;XNMASKEN_ID=900</ext-link>. Accessed 7 March, 2014.</mixed-citation>
</ref>
<ref id="pone.0112414-Cohen1"><label>15</label>
<mixed-citation publication-type="other" xlink:type="simple">Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences. Hillsdale: Lawrence Erlbaum Associates.</mixed-citation>
</ref>
<ref id="pone.0112414-Higgins2"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Egger1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Ahmadi1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ahmadi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arastoo</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Nikbakht</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zahednejad</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rajabpour</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients</article-title>. <source>Iran Red Crescent Med J</source> <volume>15</volume>: <fpage>449</fpage>–<lpage>454</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Ahmadi2"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ahmadi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nikbakh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arastoo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Habibi</surname><given-names>AH</given-names></name> (<year>2010</year>) <article-title>The Effects of a yoga intervention on balance, speed and endurance of walking, fatigue and quality of life in people with multiple sclerosis</article-title>. <source>J Hum Kinet</source> <volume>23</volume>: <fpage>71</fpage>–<lpage>78</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Doulatabad1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doulatabad</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Nooreyan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Doulatabad</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Noubandegani</surname><given-names>ZM</given-names></name> (<year>2012</year>) <article-title>The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis</article-title>. <source>Afr J Tradit Complement Altern Med</source> <volume>10</volume>: <fpage>49</fpage>–<lpage>52</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Garrett1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garrett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Larkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saunders</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jakeman</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial</article-title>. <source>Mult Scler</source> <volume>19</volume>: <fpage>782</fpage>–<lpage>789</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Garrett2"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garrett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Larkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saunders</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jakeman</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Exercise in the community for people with multiple sclerosis - A follow-up of people with minimal gait impairment</article-title>. <source>Mult Scler</source> <volume>19</volume>: <fpage>790</fpage>–<lpage>798</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Hogan1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hogan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kehoe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Larkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Coote</surname><given-names>S</given-names></name> (<year>2014</year>) <article-title>The Effect of Community Exercise Interventions for People with MS Who Use Bilateral Support for Gait</article-title>. <source>Mult Scler Int</source> <volume>2014</volume>: <fpage>109142</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Oken1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oken</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Kishiyama</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zajdel</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bourdette</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Carlsen</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Randomized controlled trial of yoga and exercise in multiple sclerosis</article-title>. <source>Neurology</source> <volume>62</volume>: <fpage>2058</fpage>–<lpage>2064</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Rahnama1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rahnama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Namazizadeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Etemadifar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bambaeichi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Arbabzadeh</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Effects of yoga on depression in women with multiple sclerosis</article-title>. <source>Journal of Isfahan Medical School</source> <volume>29</volume>: <fpage>483</fpage>–<lpage>490</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Velikonja1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Velikonja</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Curic</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ozura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jazbec</surname><given-names>SS</given-names></name> (<year>2010</year>) <article-title>Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis</article-title>. <source>Clin Neurol Neurosurg</source> <volume>112</volume>: <fpage>597</fpage>–<lpage>601</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer3"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langhorst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>A</given-names></name> (<year>2013</year>) <article-title>Quality of life and mental health in patients with chronic diseases who regularly practice yoga and those who do not: a case-control study</article-title>. <source>Evid Based Complement Alternat Med</source> <volume>2013</volume>: <fpage>702914</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer4"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langhorst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Michalsen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Predictors of yoga use among internal medicine patients BMC Complement Altern Med</article-title>. <volume>13</volume>: <fpage>172</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer5"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lange</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Klose</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2012</year>) <article-title>Yoga for breast cancer patients and survivors: a systematic review and meta-analysis</article-title>. <source>BMC cancer</source> <volume>12</volume>: <fpage>412</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer6"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Haller</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>A systematic review and meta-analysis of yoga for low back pain</article-title>. <source>Clin J Pain</source> <volume>29</volume>: <fpage>450</fpage>–<lpage>460</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer7"><label>31</label>
<mixed-citation publication-type="other" xlink:type="simple">Cramer H, Lauche R, Haller H, Dobos G, Michalsen A (2014) A systematic review of yoga for heart disease. Eur J Prev Cardiol. doi:10.1177/2047487314523132.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer8"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Haller</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Steckhan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Michalsen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis</article-title>. <source>Int J Cardiol</source> <volume>173</volume>: <fpage>170</fpage>–<lpage>183</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer9"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lauche</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langhorst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2012</year>) <article-title>Effectiveness of yoga for menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Evid Based Complement Alternat Med</source> <volume>2012</volume>: <fpage>863905</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Cramer10"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Krucoff</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dobos</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>Adverse Events Associated with Yoga: A Systematic Review of Published Case Reports and Case Series</article-title>. <source>PLoS ONE</source> <volume>8</volume>: <fpage>e75515</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Senders1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Senders</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wahbeh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Spain</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Shinto</surname><given-names>L</given-names></name> (<year>2012</year>) <article-title>Mind-body medicine for multiple sclerosis: a systematic review</article-title>. <source>Autoimmune Dis</source> <volume>2012</volume>: <fpage>567324</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-S1"><label>36</label>
<mixed-citation publication-type="other" xlink:type="simple">Sá MJ (2013) Exercise therapy and multiple sclerosis: a systematic review. J Neurol. doi:10.1007/s00415-013-7183-9.</mixed-citation>
</ref>
<ref id="pone.0112414-Boehm1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boehm</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ostermann</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Milazzo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bussing</surname><given-names>A</given-names></name> (<year>2012</year>) <article-title>Effects of yoga interventions on fatigue: a meta-analysis</article-title>. <source>Evid Based Complement Alternat Med</source> <volume>2012</volume>: <fpage>124703</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Yadav1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yadav</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bever</surname><given-names>C</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Bowen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bowling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weinstock-Guttman</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology</article-title>. <source>Neurology</source> <volume>82</volume>: <fpage>1083</fpage>–<lpage>1092</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Yadav2"><label>39</label>
<mixed-citation publication-type="other" xlink:type="simple">Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, <etal>et al</etal>.. (2014) Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Available: <ext-link ext-link-type="uri" xlink:href="https://www.aan.com/Guidelines/Home/GetGuidelineContent/643" xlink:type="simple">https://www.aan.com/Guidelines/Home/GetGuidelineContent/643</ext-link>. Accessed 5 June, 2014.</mixed-citation>
</ref>
<ref id="pone.0112414-Schulz1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schulz</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Chalmers</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>1995</year>) <article-title>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</article-title>. <source>JAMA</source> <volume>273</volume>: <fpage>408</fpage>–<lpage>412</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Gartlehner1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gartlehner</surname><given-names>G</given-names></name> (<year>2008</year>) <article-title>Assessment of adverse effects and applicability–two areas not (yet) covered adequately in Cochrane reports</article-title>. <source>Z Evid Fortbild Qual Gesundhwes</source> <volume>102</volume>: <fpage>497</fpage>–<lpage>502</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-ArmijoOlivo1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Armijo-Olivo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ospina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>da Costa</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saltaji</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials</article-title>. <source>PLOS One</source> <volume>9</volume>: <fpage>e96920</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Hetherington1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hetherington</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dickersin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chalmers</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meinert</surname><given-names>CL</given-names></name> (<year>1989</year>) <article-title>Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians</article-title>. <source>Pediatrics</source> <volume>84</volume>: <fpage>374</fpage>–<lpage>380</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Egger2"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jüni</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bartlett</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Holenstein</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sterne</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study</article-title>. <source>Health Technology Assessment</source> <volume>7</volume>: <fpage>1</fpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-Schulz2"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schulz</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Moher</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials</article-title>. <source>Ann Intern Med</source> <volume>152</volume>: <fpage>726</fpage>–<lpage>732</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-National1"><label>46</label>
<mixed-citation publication-type="other" xlink:type="simple">National Multiple Sclerosis Society (2008) Management of MS-related fatigue. New York: National Multiple Sclerosis Society.</mixed-citation>
</ref>
<ref id="pone.0112414-LatimerCheung1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Latimer-Cheung</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Martin Ginis</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Hicks</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Motl</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Pilutti</surname><given-names>LA</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Development of evidence-informed physical activity guidelines for adults with multiple sclerosis</article-title>. <source>Arch Phys Med Rehabil</source> <volume>94</volume>: <fpage>1829</fpage>–<lpage>1836</lpage>.</mixed-citation>
</ref>
<ref id="pone.0112414-National2"><label>48</label>
<mixed-citation publication-type="other" xlink:type="simple">National Collaborating Centre for Chronic Conditions (2004) Multiple Sclerosis: National clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians (UK).</mixed-citation>
</ref>
</ref-list></back>
</article>